trending Market Intelligence /marketintelligence/en/news-insights/trending/_iL0mahgHUFEcaddN2MmDA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Kalytera Therapeutics appoints CEO; COO resigns

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Kalytera Therapeutics appoints CEO; COO resigns

Kalytera Therapeutics Inc. appointed Robert Farrell permanent CEO.

Farrell had been serving as the company's interim CEO. He previously served Titan Pharmaceuticals Inc. as president and CEO and as CFO.

Additionally, Kalytera said David Bassa resigned as COO, while Pini Ben-Elazar resigned as a director.